Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVANCE MPI 2: Regadenoson vs Adenoscan in MPI
NCT00208312Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of regadenoson in coronary artery disease (CAD), sponsored by Gilead Sciences. Started Apr 2004; status: completed.
02
Drugs
regadenoson
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00208312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00208312.